(1)
Changsatja, S.; Kositamongkol, C. .; Thamlikitkul, L. .; Phisalprapa, P. .; Komonpaisarn, T. . COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND. ICOPH 2025, 9, 45-67.